Cempra Pharmaceuticals and Biovista Enter Agreement for Macrolide Clinical Trial Design Support Studies

Cempra Pharmaceuticals, Inc., and Biovista, Inc., announced today that they have entered into a research agreement to systematically identify and profile adverse event associations for members of the macrolide drug class.... [more]

View complete Press Release article